Company Overview
Snapshot
Founded in January 2010 by Moshe Becker and Hayit Greenspan, RadLogics operates with 1–10 employees. The company has raised $8.85 million across three funding rounds from seven investors. In September 2020, RadLogics announced FDA clearance and validation for its AI-powered application designed to support chest X-ray triage and prioritization.
Business overview
RadLogics develops AI-powered solutions to enhance radiologists' productivity and improve patient outcomes through medical imaging analytics. The company utilizes AI and machine learning for image analysis and advanced big data analytics to process imaging data, aiming to reduce diagnostic turnaround times from hours to minutes by automating detection and report generation. Its patented AI medical image analysis platform facilitates rapid development and deployment of AI algorithms and integrates seamlessly into existing radiology workflows. RadLogics' platform includes FDA-cleared applications for automatic analysis of DICOM data from CT and X-ray scans, providing automated detection, measurements, and key-images. The company operates in the Health Tech & Life Sciences sector, specifically within Digital Healthcare, Medical Decision Support, and Digital Medical Diagnostics, serving healthcare providers globally.
Strategic signal
In September 2020, RadLogics secured FDA clearance and validation for its AI-powered application for chest X-ray triage and prioritization. This milestone signals significant regulatory approval and market readiness for its diagnostic tools, indicating a strong potential for improving efficiency in radiology departments and enhancing patient care through faster, AI-assisted diagnoses, particularly relevant for high-volume imaging scenarios.
Log in to access full profile ›Company Intelligence Q&A
- What was a significant regulatory achievement for RadLogics?
- In September 2020, RadLogics announced FDA clearance and validation for its AI-powered application to support chest X-ray triage and prioritization, marking a key regulatory approval for its medical imaging solutions.
- What advancements did RadLogics announce regarding COVID-19 solutions?
- In November 2020, RadLogics announced new advancements and research in its AI-powered COVID-19 medical imaging solutions, indicating ongoing development to address the pandemic's diagnostic challenges.
- What was the outcome of RadLogics' participation in RSNA 2018?
- In November 2018, RadLogics showcased its Virtual-Resident™ image analysis clinical decision support solution for radiologists at RSNA, demonstrating up to a 44% improvement in radiologists' productivity.
- Did RadLogics expand deployment of its AI solution for COVID-19 patients?
- In April 2020, RadLogics expanded the deployment of its AI-powered solution to support chest imaging for COVID-19 patients, indicating a rapid response to emerging healthcare needs.
- What was a key partnership announced by RadLogics in 2019?
- In December 2019, RadLogics announced an agreement to distribute its AI algorithms on the Nuance AI Marketplace, expanding the reach and integration of its diagnostic tools.